Similar effect on REM sleep but differential effect on slow wave sleep of the two 5-HT uptake inhibitors zimeldine and alaproclate in cats and rats
- 1 March 1987
- journal article
- research article
- Published by Springer Nature in Journal Of Neural Transmission-Parkinsons Disease and Dementia Section
- Vol. 68 (1-2) , 127-144
- https://doi.org/10.1007/bf01244644
Abstract
Sleep and waking in cats and rats were studied 6–10 hours following acute administration of zimeldine, alaproclate or saline. The effects on slow wave sleep of the two compounds markedly differed in the cats. Following zimeldine, sleep with a high amount of synchronized slow waves (SWS-2) was increased, and total sleep was unchanged. Following alaproclate, SWS-2 did not increase, and total sleep was reduced. In the rats, zimeldine increased SWS-2 during the first 4 hours after administration, while there was no change in SWS following alaproclate. Both zimeldine and alaproclate increased REM latency and reduced REM sleep in both species with somewhat more pronounced effects in cats than in rats. The results on SWS-2 following zimeldine are consistent with earlier results following serotonin depletion in both species. The differential effects on SWS-2 are discussed in terms of regional differences in uptake inhibition and other differences between the two uptake inhibitors. The results on REM sleep confirm earlier results involving serotonin uptake inhibitors and serotonin precursor loading and indicate that increased synaptic serotonin concentrations suppress REM sleep.This publication has 50 references indexed in Scilit:
- Anatomical Features and Physiological Properties of Central Serotonin NeuronsPharmacopsychiatry, 1985
- Alaproclate a novel antidepressant?Acta Psychiatrica Scandinavica, 1985
- In vivo andin vitro studies on the potentiation of muscarinic receptor stimulation by alaproclate, a selective 5-HT uptake blockerJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1985
- Alaproclate, a new selective 5-HT uptake inhibitor with therapeutic potential in depression and senile dementiaJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1984
- Test-specific effects of the 5-HT reuptake inhibitors alaproclate and zimelidine on pain sensitivity and morphine analgesiaJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1980
- Reevaluation of the indoleamine hypothesis of depression. Evidence for a reduction of functional activity of central 5-HT systems by antidepressant drugsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1979
- Efflux of phenylalanine and tryptophan from cerebral cortex slices of adult and 7-day-old ratsActa Physiologica Scandinavica, 1978
- Sleep-waking patterns in cats after administration of fenfluramine and other monoaminergic modulating drugsPharmacology Biochemistry and Behavior, 1973
- Differential Effect of para-Chlorophenylalanine on the Two Slow Wave Sleep Stages in the CatActa Physiologica Scandinavica, 1972
- INTERVAL BETWEEN ONSET OF SLEEP AND RAPID-EYE-MOVEMENT SLEEP AS AN INDICATOR OF DEPRESSIONThe Lancet, 1972